Myeloproliferative Neoplasms

This publication has 50 references indexed in Scilit:

• TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
  Leukemia, 2009
• Is JAK2 V617F mutation more than a diagnostic index?
  Leukemia Research, 2009
• Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
  Leukemia, 2008
• Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
  Blood, 2008
• Leukemic blasts in transformed JAK2-V617F–positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.
  Blood, 2007
• Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera
  Leukemia, 2007
• Epidemiology of the Myeloproliferative Disorders Polycythemia Vera and Essential Thrombocythemia
  Seminars in Thrombosis and Hemostasis, 2006
• JAK2^V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance
  British Journal of Haematology, 2005
• Four-Color Flow Cytometry Identifies Virtually All Cytogenetically Abnormal Bone Marrow Samples in the Workup of Non-CML Myeloproliferative Disorders
  American Journal of Clinical Pathology, 2003
• Cytogenetic and Molecular Genetic Aspects of Essential Thrombocythemia
  Acta Haematologica, 2002